On that note, let's dive in and investigate how the bull thesis for buying Vertex stock just got even stronger. Vertex's push ...

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...

On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...

Xavier, who leads biotech venture investing for the big drugmaker, expects an uptick in IPOs as well as renewed interest in ...

In a report released today, Liisa Bayko from Evercore ISI maintained a Hold rating on Editas Medicine (EDIT – Research Report), with a ...

Trinasolar has recently reached a significant milestone, delivering more than 1 GW of its Vertex N 720W series modules to the Jinsha River upstream clean energy plant. This project has now entered a ...

Mobile-first customer experience company Airship today revealed an expansion of its long-standing collaboration with Google Cloud, including the integration of Google Cloud's Vertex AI platform into ...

Lonza Group AG / Key word (s): Quarter Results Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024 24-Oct-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR ...

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their ...

With interest rate cuts and China’s stimulus fueling growth, emerging market stocks are gaining momentum. As the global ...